Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Zhang Website

Lisa J. Zhang, Ph.D.

Selected Publications

1)  Zhang L, Gaskins K, Yu Z, Xiong Y, Merino MJ, Kebebew E.
An in vivo mouse model of metastatic human thyroid cancer.
Thyroid. 24: 695-704, 2014.
[Journal]
2)  Jain M, Zhang L, He M, Zhang YQ, Shen M, Kebebew E.
TOP2A is overexpressed and is a therapeutic target for adrenocortical carcinoma.
Endocr. Relat. Cancer. 20: 361-70, 2013.
[Journal]
3)  Nilubol N, Zhang L, Kebebew E.
Multivariate analysis of the relationship between male sex, disease-specific survival, and features of tumor aggressiveness in thyroid cancer of follicular cell origin.
Thyroid. 23: 695-702, 2013.
[Journal]
4)  Zhang L, He M, Zhang Y, Nilubol N, Shen M, Kebebew E.
Quantitative high-throughput drug screening identifies novel classes of drugs with anticancer activity in thyroid cancer cells: opportunities for repurposing.
J. Clin. Endocrinol. Metab. 97: E319-28, 2012.
[Journal]
5)  Zhang L, Rahbari R, He M, Kebebew E.
CDC23 regulates cancer cell phenotype and is overexpressed in papillary thyroid cancer.
Endocr. Relat. Cancer. 18: 731-42, 2011.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 6/5/2014.